CVIA Journal

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Heart failure (HF) represents one of the most pressing health challenges globally, affecting more than 64 million people worldwide. Despite therapeutic progress, HF remains a leading cause of hospitalization and mortality, particularly in patients with reduced ejection fraction (HFrEF), with annual costs, including hospitalizations, pharmacotherapy, and productivity losses, measured in the hundreds of billions of dollars. Readmissions remain common: roughly one in four patients is rehospitalized within 30 days in many healthcare (more…)